2011
DOI: 10.1016/j.ejmech.2011.06.023
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT1A receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(15 citation statements)
references
References 34 publications
0
15
0
Order By: Relevance
“…One study examined the effects of bridgehead fluoromethyl group (cubyl, adamantly and others) with some success (Al Hussainy et al, 2011). RWAY- which contains a cycloheptyl has been studied with 11 C-RWAY, although human studies have indicated interference by a lipophilic metabolite (Zhang et al, 2007).…”
Section: Resultsmentioning
confidence: 99%
“…One study examined the effects of bridgehead fluoromethyl group (cubyl, adamantly and others) with some success (Al Hussainy et al, 2011). RWAY- which contains a cycloheptyl has been studied with 11 C-RWAY, although human studies have indicated interference by a lipophilic metabolite (Zhang et al, 2007).…”
Section: Resultsmentioning
confidence: 99%
“…For this goal, compounds 78 were synthesized, including the 18 F tracers for imaging. 88,89 In rats, all three compounds showed a higher uptake in the hippocampus and cortex, regions where the 5-HT 1A receptor would be expected. Compound 78a showed slightly higher uptake in the liver than 78b, which was explained by the enhanced hepatic processing of the cubyl moiety.…”
Section: Journal Of Medicinal Chemistrymentioning
confidence: 96%
“…69 Radiolabeled compound 64 ( 123 I) was developed as a probe for in vivo Staudinger ligation to azide tagged antibodies. 70 In comparison to desferrioxamine type probes with 89 Zr or 67/68 Ga radiolabeling, compound 64 showed poor pharmacokinetics and thus was not explored further in this study. As a way to improve upon compound 14a for inhibition of monoamine oxidase B, the series of compounds 14b,c were synthesized.…”
Section: Journal Of Medicinal Chemistrymentioning
confidence: 99%
“…We also thank the Ministry of Higher Education (Malaysia) for funding structural studies through the High-Impact Research scheme (UM.C/HIR/MOHE/SC/12). Hussainy et al, 2011;Moussa et al, 2011), anti-convulsant (Kamiński et al, 2011, anti-microbial (Sheng et al, 2011), anti-cancer (Yang et al 2011) and histamine antagonist (Liu et al, 2011). In continuation of our interest in the chemical and pharmacological properties of 1,4-piperazine derivatives (Kadi et al, 2010), we synthesized the title compound, (I), as an intermediate for potential chemotherapeutic agents.…”
Section: Crystal Datamentioning
confidence: 99%